UPDATE: WATCH THE DISCUSSION (YOUTUBE) BELOW:
The next TigerTalks in the City is scheduled for Thursday, November 30th and will focus on “Entrepreneurship in the Life Sciences” and feature Princeton's Keller Center faculty member Shahram Hejazi and two startup founders. This TigerTalks event will explore the challenges and opportunities, from the perspective of investor and founder, of biotech and digital health startups. Joining Hejazi will be Hahn Kim *07, Director of Small Molecule Screening Center and Founder of Crescenta Biosciences, and Craig Limoli '12, Co-Founder and CEO of WellSheet. The panel will be moderated by Anne-Marie Maman '84, Executive Director of Princeton Entrepreneurship Council.
Shahram Hejazi is a life science investor and entrepreneur with general management experience in both early-stage ventures and large global companies, and has founded and/or directed the growth of more than two dozen startup companies. He is a partner at the venture firm BioAdvance with responsibility for investments in research tools, devices, diagnostics, and digital health. He is also a Lecturer in Entrepreneurship at Princeton.
Hahn Kim *07 is Director of The Small Molecule Screening Center that enables the discovery of cutting-edge biology on Princeton's campus through the screening and innovation of small molecule compounds. He is also Founder of Crescenta Biosciences, a pioneering new small molecule drug discovery company focused on developing novel therapeutic approaches for the treatment of human disease.
Craig Limoli '12 founded WellSheet two years ago after working at IBM Watson's health business. WellSheet is a web application that improves clinicians' productivity and care quality when treating complex patients, prioritizing clinically relevant and important information across sources with machine learning. They recently closed an $800,000 seed round.
Space is limited, so we encourage you to register early to ensure a seat at this exciting event that will explore the opportunities, challenges and learnings in building and investing in biotech and digital health companies.
6:00 p.m. Check-In (refreshments & light hors-d'oeuvres)
6:30 p.m. Panel Discussion
7:30 p.m. Networking Reception